Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03431051
Other study ID # Healthy Beverage Initiative
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 18, 2018
Est. completion date December 31, 2022

Study information

Verified date August 2022
Source California Pacific Medical Center Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study is designed to determine if instituting a Healthy Beverage Initiative (HBI) at hospitals influences health and wellness of employees over a 12 month period.


Description:

To examine whether HBI is associated with decreased adiposity over a 12-month time period, in comparison to individuals identically assessed but not exposed to a HBI. Specifically, do those exposed to the HBI decrease in measures of adiposity, BMI, and sugar sweetened beverage (SSB) intake? Do they decrease more in those measures as compared to those not exposed to the HBI?


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 648
Est. completion date December 31, 2022
Est. primary completion date November 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - The participant speaks and reads English. - The participant consumes three or more sugar-sweetened beverages a week. - The participant expects to be able to participate for all 3 visits (baseline, 6 months, and 12 months). Exclusion Criteria: The participant is planning an extended leave of absence and/or family medical leave of absence over the next 12 months.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Healthy Beverage Initiative
A Healthy Beverage Initiative will be instituted at two hospital campuses.

Locations

Country Name City State
United States California Pacific Medical Center San Francisco California

Sponsors (3)

Lead Sponsor Collaborator
California Pacific Medical Center Research Institute Laura and John Arnold Foundation, University of California, San Francisco

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Abdominal adiposity Study participants at HBI campuses will show improvements (specifically, decreases) in indices of abdominal adiposity measured using waist circumference in centimeters. About one year.
Primary Abdominal adiposity Study participants at HBI campuses will show improvements (specifically, decreases) in indices of abdominal adiposity measured using sagittal abdominal diameter in centimeters. About one year.
Secondary Body Mass Index (BMI) Study participants at HBI campuses will show improvements (specifically, decreases) in body mass index [BMI] measured using height in centimeters and weight in kilograms to be calculated into BMI in kg/m^2. About one year.
Secondary Sugar Sweetened Beverage Intake Study participants at HBI campuses will show improvements (specifically, decreases) in SSB intake measured by the BEVQ (beverage food frequency questionnaire). About one year.
See also
  Status Clinical Trial Phase
Terminated NCT02606591 - Houston Independent School District (HISD) Yoga Evaluation N/A